Association for Ocular Pharmacology and Therapeutics

Add links
From Wikipedia, the free encyclopedia

The Association for Ocular Pharmacology and Therapeutics (AOPT) is an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications. The mission of AOPT is the sustenance of a scientific network aiming the dissemination of knowledge in the field of ocular disease, pharmacology and therapeutics.

History[edit]

AOPT was begun informally in the 1970s by Dr. George Chiou[1][2] as special sessions at the Federation of American Societies for Experimental Biology[3] conferences. It grew to an official separate Symposium of Ocular Pharmacology meeting of academicians, clinicians, and pharmaceutical industry at Novi, Michigan in August 1993.[4] The participants voted to charter the organization and this was accomplished the next year with the first AOPT meeting held in New Orleans, Louisiana in January 1995. The founding board comprised Drs. George Chiou (president), David Lee (vice-president), Hitoshi Shichi (treasurer), and Herbert Kaufman (trustee). During the early FASEB years, Chiou also established the Journal of Ocular Pharmacology, now the Journal of Ocular Pharmacology & Therapeutics. The history of AOPT is closely related to the Association for Research in Vision and Ophthalmology (ARVO).[5]

Activity[edit]

The mission of AOPT is to help researchers and eye-care professionals in their efforts toward the understanding and the treatment of eye diseases. AOPT scientific dissemination involves preclinical and clinical pharmacologists and researchers. Scientific dissemination is promoted through biennial meetings [6] and the peer-reviewed journal: Journal of Ocular Pharmacology and Therapeutics (JOPT).

Journal[edit]

JOPT is the official journal of AOPT. It is a multidisciplinary journal that covers the latest findings related to pharmacodynamics and pharmacokinetics of pharmaceuticals used in the treatment of ocular disorders.[7] The journal is published 10 times per year. This journal is peer reviewed with on line access prior to journal publication and it is available in 170 countries (http://home.libertpub.com). The journal also publishes Special Issues. The next one is "Next Generation Tissue Engineering: Inspired Models for Ophthalmic Drug Discovery". (Ashwath Jayagopal and Héloïse Ragelle guest editors. The current editor-in-chief of JOPT is W. Daniel Stamer, PhD.(Duke University, Durham, NC http://medschoolduke.edu/about-us/our-faculty/w-daniel-stamer ) On line ISSN 1557-7732 with an impact factor of 1.782. Affiliated with AOPT and ISOPT Clinical ( International Symposium on Ocular Pharmacology & Therapeutics Clinical) (http://isopclinical.com)

Composition[edit]

AOPT has a diverse leadership and membership which include principal investigators, scientists, medical professionals, technicians, and students with an interest in ocular pharmacology and therapeutics. The directive committee and members come from academic institutions and private companies worldwide.

2018-2020 Board of directors[edit]

  • President: Dr. Filippo Drago
  • Vice-President/President Elect: Dr. Ash Jayagopal
  • Immediate Past President: Dr. Thomas Yurio
  • Treasurer: Dr. Shusheng Wang
  • Secretary: Dr. Cheryl Rowe-Rendleman
  • Trustees: Dr. Sanjoy Bhattacharya, Dr. Claudio Bucolo, Dr. Dorette Ellis, Dr. Shahid Husain, Dr. Goldis Malek, Dr. Najam Sharif, Dr. Dan Stamer, Dr. Chi-ho To, Dr. Heping Xu
  • Social Media Trustee/Advisor: Dr. Malinda Fitzgerald
  • Advisor: Carol Toris

2015-2017 Board of directors[edit]

  • President: Dr. Thomas Yorio
  • Vice-President: Dr. Filippo Drago
  • Treasurer: Dr. Peter Kador
  • Secretary: Dr. Carol Toris
  • Trustees: Dr. Malinda Fitzgerald, Dr. Ash Jayagopal, Dr. Uday Kompella, Dr. Cameron Millar, Dr. Iok-Hou Pang, Dr. Ganesh Prasanna, Dr. Shusheng Wang, Dr. Christine Wildsoet

[8]

2013-2015 Board of directors[edit]

  • President: Dr. Achim H. Krauss
  • Vice-President: Dr. Thomas Yorio
  • Treasurer: Dr. Ganesh Prasanna
  • Secretary: Dr. Jeff Kiel
  • Trustees: Dr. Abbot Clark, Dr. Julie Crider, Prof. Filippo Drago, Dr. Malinda Fitzgerald, Dr. Juana Gallar, Dr. Peter Kador, Dr. W. Daniel Stamer, Dr. Oliver Zeitz

Related societies[edit]

Members of AOPT and societies in the field of eye research, gather every year at the annual ARVO meeting, in which the latest findings in vision and ophthalmology research are disseminated. Societies in the field of eye research span from preclinical to clinical and a few of these societies are hereby listed:

See also[edit]

References[edit]

  1. ^ "George C.Y. Chiou, Ph.D. - Texas A&M Health Science Center". Medicine.tamhsc.edu. 2007-07-18. Retrieved 2013-10-21.
  2. ^ George Chiou is the founder and first president of AOPT. Ophthalmic Toxicology, 2nd edition. Taylor and Francis. Philadelphia, PA.
  3. ^ "Association Management | Society Management Services | Federation of American Societies for Experimental Biology". Faseb.org. 2013-09-24. Retrieved 2013-10-21.
  4. ^ Recent Advances in Ocular Pharmacology. Symposium proceedings. Novi, Michigan, August 8–10, 1993.J Ocul Pharmacol. 1994 Spring;10(1):1-410.
  5. ^ GEORGE C.Y. CHIOU. The Birth of Association for Ocular Pharmacology and Therapeutics. Journal of Ocular Pharmacology and Therapeutics. Fall 1995, 11(3): 191-192. doi:10.1089/jop.1995.11.191.
  6. ^ "AOPT Meetings". Aopt.org. Archived from the original on 2013-10-21. Retrieved 2013-10-21.
  7. ^ "Journal of Ocular Pharmacology and Therapeutics". Liebertpub.com. Retrieved 2013-10-21.
  8. ^ "AOPT board of directors". Retrieved 2015-05-03.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Association_for_Ocular_Pharmacology_and_Therapeutics&oldid=1115111605"